Stockscreener 앱 받기
233.83
5.74%
-14.23
시장 영업 전:
231.97
-1.86
-0.80%
전일 마감가:
$248.06
열려 있는:
$240.39
하루 거래량:
1.41M
Relative Volume:
1.54
시가총액:
$16.84B
수익:
$2.96B
순이익/손실:
$487.70M
주가수익비율:
35.03
EPS:
6.6758
순현금흐름:
$344.00M
1주 성능:
-6.98%
1개월 성능:
-3.99%
6개월 성능:
-8.38%
1년 성능:
+3.45%
1일 변동 폭
$228.40
$243.14
1주일 범위
$228.40
$254.60
52주 변동 폭
$187.43
$322.34
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
233.83 | 17.87B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
485.85 | 175.28B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
163.88 | 47.07B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
80.65 | 39.90B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
247.11 | 36.85B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
42.88 | 35.23B | 28.43B | 1.16B | 1.26B | 1.4457 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
Barclays PLC Sells 59,572 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
3 Reasons to Sell WST and 1 Stock to Buy Instead - Finviz
West Pharmaceutical Services launches West Synchrony S1 prefillable syringe system - Traders Union
West Pharmaceutical Services (NYSE:WST) Shares Gap DownShould You Sell? - MarketBeat
West Pharmaceutical CEO Eric Green to retire in second half 2026 - Investing.com Australia
West Pharmaceutical (WST) slides as investors digest CEO retirement plan and conference commentary - Quiver Quantitative
West Pharmaceutical at Barclays Conference: Strategic Shifts and Growth Projections - Investing.com
West Pharmaceutical (WST) Announces CEO Eric Green's Upcoming Re - GuruFocus
West Pharmaceutical (WST) CEO to Retire, Leadership Transition P - GuruFocus
West Pharmaceutical Services (WST) Announces CEO Retirement Plans - GuruFocus
West Pharmaceutical Services, Inc. Announces Eric M. Green Plans to Retire as Chief Executive Officer - marketscreener.com
West Pharma CEO Eric Green to retire after 11 years at the helm - Reuters
After doubling sales and 350% return, West Pharma chief plans exit - Stock Titan
West Pharmaceutical Services to Present at Two Healthcare Conferences - MyChesCo
LGT Group Foundation Sells 14,341 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Pharmaceutical Packaging Market to Exceed $219B by 2031 as Sustainability & Injectable Drug Packaging Reshape Industry Dynamics, Says Mordor Intelligence - GlobeNewswire Inc.
Are Wall Street analysts bullish on West Pharmaceutical Services stock? - MSN
Female expert achievements celebrated with new blog articles, West Pharmaceutical Services asserts - Traders Union
West Pharmaceutical Services, Inc. (NYSE:WST) Given Average Rating of "Buy" by Analysts - MarketBeat
Neo Ivy Capital Management Makes New Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
Aug Closing: Will West Pharmaceutical Services Inc outperform small cap indexesMarket Rally & Scalable Portfolio Growth Ideas - baoquankhu1.vn
West Pharma climbs 0.62% following robust Q4 results and GLP-1 momentum, securing the 501st spot with $260M in trading volume as analysts highlight a 25% price premium - Bitget
S&P 500 Stock Analysis: Amazon's Potential vs. Akamai & West Pharma ConcernsNews and Statistics - IndexBox
What is Zacks Research's Forecast for WST Q1 Earnings? - MarketBeat
Wearable Injectors Market Set to Witness Rapid Growth Through - openPR.com
West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain - Morningstar
William Blair Investment Management LLC Trims Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Sold by American Century Companies Inc. - MarketBeat
Transitioning your drug from a vial to combination product - Fierce Biotech
West Pharmaceutical Services, Inc. Announces Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
West Pharmaceutical (WST) SVP granted 1,285 RSUs and 3,057 options - Stock Titan
West Pharmaceutical (NYSE: WST) CEO granted new RSUs and stock options - Stock Titan
WEST PHARMACEUTICAL (WST) HR chief granted RSUs and stock options - Stock Titan
West Pharmaceutical SVP granted RSUs and options | WST SEC FilingForm 4 - Stock Titan
West Pharmaceutical (NYSE: WST) CFO awarded new RSUs and stock options - Stock Titan
West Pharmaceutical (WST) SVP awarded restricted stock units and options - Stock Titan
West Pharmaceutical Services Margins Slip To 16.3% Raising Questions Around Bullish Growth Narratives - Sahm
West Pharmaceutical (WST) VP, CAO receives RSU and stock option grants - Stock Titan
Champlain Investment Partners LLC Boosts Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
WST Technical Analysis & ETF Price Forecast - Intellectia AI
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financ - GuruFocus
West Pharmaceutical Services : 2025 Annual Report (2490a2) - marketscreener.com
West to Participate in Upcoming Investor Conferences - marketscreener.com
West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Promising 25% Upside Potential - DirectorsTalk Interviews
West Pharmaceutical Services, Inc. $WST Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
APG Asset Management N.V. Sells 244,966 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Is West Pharmaceutical Services (WST) Pricing Too Much Growth Into Its Current Share Price? - Yahoo Finance
West Pharmaceutical Services Inc (MIL:1WST) Stock Price, Trades & News - GuruFocus
Findlay Park Partners LLP Has $210.42 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.07%
자본화:
|
볼륨(24시간):